GB0620830D0 - Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases - Google Patents

Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases

Info

Publication number
GB0620830D0
GB0620830D0 GBGB0620830.0A GB0620830A GB0620830D0 GB 0620830 D0 GB0620830 D0 GB 0620830D0 GB 0620830 A GB0620830 A GB 0620830A GB 0620830 D0 GB0620830 D0 GB 0620830D0
Authority
GB
United Kingdom
Prior art keywords
steroids
combination
respiratory diseases
treat chronic
chronic respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0620830.0A
Other versions
GB2430622A (en
GB2430622B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0502949A external-priority patent/GB0502949D0/en
Priority claimed from GB0526124A external-priority patent/GB0526124D0/en
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to GB0716700A priority Critical patent/GB2442828A/en
Priority claimed from PCT/GB2006/000482 external-priority patent/WO2006085102A1/en
Publication of GB0620830D0 publication Critical patent/GB0620830D0/en
Publication of GB2430622A publication Critical patent/GB2430622A/en
Application granted granted Critical
Publication of GB2430622B publication Critical patent/GB2430622B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0620830A 2005-02-11 2006-02-13 Inhaled combination therapy Expired - Fee Related GB2430622B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0716700A GB2442828A (en) 2005-02-11 2006-02-13 Combination of a methylxanthine compound and a steroid to treat chronic respiratory disease

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0502949A GB0502949D0 (en) 2005-02-11 2005-02-11 Combination therapy
GB0526124A GB0526124D0 (en) 2005-12-22 2005-12-22 Inhaled combination therapy
PCT/GB2006/000482 WO2006085102A1 (en) 2005-02-11 2006-02-13 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases

Publications (3)

Publication Number Publication Date
GB0620830D0 true GB0620830D0 (en) 2006-12-13
GB2430622A GB2430622A (en) 2007-04-04
GB2430622B GB2430622B (en) 2008-03-05

Family

ID=37547091

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0620830A Expired - Fee Related GB2430622B (en) 2005-02-11 2006-02-13 Inhaled combination therapy

Country Status (1)

Country Link
GB (1) GB2430622B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8918297D0 (en) * 1989-08-10 1989-09-20 Beecham Group Plc Novel treatment
GB0417481D0 (en) * 2004-08-05 2004-09-08 Etiologics Ltd Combination therapy

Also Published As

Publication number Publication date
GB2430622A (en) 2007-04-04
GB2430622B (en) 2008-03-05

Similar Documents

Publication Publication Date Title
EP1962869A4 (en) Treatment of respiratory diseases
EP1968607A4 (en) Treatment of cancer and other diseases
EP1962839A4 (en) Administration of mntor inhibitor to treat patients with cancer
EP1986624A4 (en) Method of using abscisic acid to treat and prevent diseases and disorders
PL2379088T3 (en) Treatment of lung and pulmonary diseases and disorders
EP2004204A4 (en) Treatment of neurodegenerative diseases
EP2152865A4 (en) Methods of treatment and prevention of neurodegenerative diseases and disorders
AP2715A (en) Use of imatinib to treat liver disorders and viralinfections
EP2164505A4 (en) Treatment of chronic lung disease
PL2049127T3 (en) N-methanocarba derivatives to treat cardiac diseases
EP2056848A4 (en) Use of extracts for the treatment of viral disorders
EP1755402A4 (en) Compositions for inhalation therapy and methods of use
EP2217238A4 (en) Methods and compositions for the treatment of proteinuric diseases
EP2206714A4 (en) Agent for prevention and/or treatment of skin diseases
EP2049899A4 (en) Methods to prevent and treat diseases
HK1119592A1 (en) Interferon lambda therapy for treatment of respiratory diseases
GB0610183D0 (en) Treatment of neurodegenerative diseases
GB0603181D0 (en) Treatment of neurodegenerative and psychiatric diseases
EP2001488A4 (en) Prevention and treatment of cancer and other diseases
EP1838316A4 (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
EP1930017A4 (en) Composition effective for prevention and treatment of adult disease
IL173370A0 (en) Combination of an anticholinergic and asteroid and its use to treat respiratory disorders by inhalation
EP2096927A4 (en) Therapeutic compositions and methods of treatment with capsianoside-type compounds
IL185114A0 (en) Use of vitamin d compounds to treat endometriosis
EP1737475A4 (en) Herbal therapy for the treatment of asthma

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20100213

S73 Revocation on comptroller's initiative (section 73/patents act 1977)

Free format text: PATENT REVOKED; PATENT REVOKED UNDER SECTION 73(2) ON 1 NOVEMBER 2010